Sun‐Ok Kim

1.2k total citations · 1 hit paper
28 papers, 1.0k citations indexed

About

Sun‐Ok Kim is a scholar working on Molecular Biology, Biomaterials and Genetics. According to data from OpenAlex, Sun‐Ok Kim has authored 28 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 4 papers in Biomaterials and 4 papers in Genetics. Recurrent topics in Sun‐Ok Kim's work include Nanoparticle-Based Drug Delivery (4 papers), Microbial Natural Products and Biosynthesis (3 papers) and Epigenetics and DNA Methylation (3 papers). Sun‐Ok Kim is often cited by papers focused on Nanoparticle-Based Drug Delivery (4 papers), Microbial Natural Products and Biosynthesis (3 papers) and Epigenetics and DNA Methylation (3 papers). Sun‐Ok Kim collaborates with scholars based in South Korea, Japan and United States. Sun‐Ok Kim's co-authors include Taeghwan Hyeon, Sung Tae Kim, Kwangjin An, Seung‐Hoon Kim, Do‐Hyun Nam, Mi‐Hyun Park, Sang‐Wook Kim, Hyon Bin Na, Ki Soo Kim and In Su Lee and has published in prestigious journals such as Journal of the American Chemical Society, Angewandte Chemie International Edition and Cancer.

In The Last Decade

Sun‐Ok Kim

26 papers receiving 1.0k citations

Hit Papers

Development of a T1 Contrast Agent for Magnetic Resonance... 2007 2026 2013 2019 2007 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sun‐Ok Kim South Korea 12 469 450 419 214 93 28 1.0k
Liang Dong China 15 282 0.6× 216 0.5× 333 0.8× 218 1.0× 69 0.7× 36 923
Gaëlle Roullin Canada 20 303 0.6× 472 1.0× 316 0.8× 219 1.0× 41 0.4× 51 1.2k
Fong‐Yu Cheng Taiwan 16 461 1.0× 456 1.0× 545 1.3× 286 1.3× 121 1.3× 35 1.1k
Yanchun Wei China 18 526 1.1× 356 0.8× 740 1.8× 305 1.4× 43 0.5× 51 1.3k
Haerim Lee South Korea 10 258 0.6× 506 1.1× 383 0.9× 241 1.1× 99 1.1× 24 970
Azhar Z. Abbasi Germany 17 491 1.0× 378 0.8× 468 1.1× 300 1.4× 93 1.0× 20 1.2k
Yuxiang Ma China 16 512 1.1× 186 0.4× 574 1.4× 382 1.8× 113 1.2× 32 1.3k
Tiancong Ma China 14 456 1.0× 291 0.6× 549 1.3× 355 1.7× 43 0.5× 22 1.0k
Hilliard L. Kutscher United States 15 403 0.9× 201 0.4× 424 1.0× 241 1.1× 38 0.4× 32 1.0k
Linji Gong China 15 543 1.2× 222 0.5× 725 1.7× 242 1.1× 47 0.5× 19 1.1k

Countries citing papers authored by Sun‐Ok Kim

Since Specialization
Citations

This map shows the geographic impact of Sun‐Ok Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sun‐Ok Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sun‐Ok Kim more than expected).

Fields of papers citing papers by Sun‐Ok Kim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sun‐Ok Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sun‐Ok Kim. The network helps show where Sun‐Ok Kim may publish in the future.

Co-authorship network of co-authors of Sun‐Ok Kim

This figure shows the co-authorship network connecting the top 25 collaborators of Sun‐Ok Kim. A scholar is included among the top collaborators of Sun‐Ok Kim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sun‐Ok Kim. Sun‐Ok Kim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jeong, Ju Hwan, et al.. (2025). Regorafenib as a potential drug for severe COVID‐19: inhibition of inflammasome activation in mice. FEBS Open Bio. 15(3). 427–435. 1 indexed citations
2.
Yu, Ji Eun, et al.. (2024). Transport of Golgi-localized β-catenin p-S47 by KIF11 or KIFC3 induces primary ciliogenesis. Molecules and Cells. 47(12). 100142–100142. 2 indexed citations
3.
Kim, Sun‐Ok, Bo Yeon Kim, & Kyung Ho Lee. (2022). Synergistic effect of anticancer drug resistance and Wnt3a on primary ciliogenesis in A549 cell-derived anticancer drug-resistant subcell lines. Biochemical and Biophysical Research Communications. 635. 1–11. 5 indexed citations
4.
Yu, Ji Eun, Sun‐Ok Kim, Jin Tae Hong, et al.. (2021). Phosphorylation of β‐catenin Ser60 by polo‐like kinase 1 drives the completion of cytokinesis. EMBO Reports. 22(12). e51503–e51503. 9 indexed citations
5.
Yu, Ji Eun, et al.. (2021). Wnt5a-induced docking of Plk1 on HEF1 promotes HEF1 translocation and tumorigenesis. Genes & Genomics. 43(5). 567–575. 1 indexed citations
6.
Asami, Yukihiro, Sun‐Ok Kim, Jun‐Pil Jang, et al.. (2020). CRM646-A, a Fungal Metabolite, Induces Nucleus Condensation by Increasing Ca2+ Levels in Rat 3Y1 Fibroblast Cells. Journal of Microbiology and Biotechnology. 30(1). 31–37. 1 indexed citations
8.
Jang, Jae‐Hyuk, Soo‐Jin Choo, Sun‐Ok Kim, et al.. (2014). Boseongazepines A–C, pyrrolobenzodiazepine derivatives from a Streptomyces sp. 11A057. Bioorganic & Medicinal Chemistry Letters. 24(7). 1802–1804. 12 indexed citations
9.
Sim, Bo‐Woong, Minsu Kim, Chaewon Park, et al.. (2013). TALEN-Mediated Gene Editing Method for GRK5-KO Mice. 37(2). 32–33. 1 indexed citations
10.
Lee, Sa-Won, et al.. (2011). Development of docetaxel-loaded intravenous formulation, Nanoxel-PM™ using polymer-based delivery system. Journal of Controlled Release. 155(2). 262–271. 133 indexed citations
11.
Yun, Minhyuk, et al.. (2010). Pharmacokinetic-Pharmacodynamic modeling of the analgesic effect of bupredermTM, in mice. Health. 2(8). 824–831. 8 indexed citations
12.
Park, In, et al.. (2008). Buprederm™, a New Transdermal Delivery System of Buprenorphine: Pharmacokinetic, Efficacy and Skin Irritancy Studies. Pharmaceutical Research. 25(5). 1052–1062. 36 indexed citations
13.
Kim, Sun‐Ok, et al.. (2007). The Effect of Data Sparsity on Prediction Accuracy in Recommender System. Journal of Internet Computing and services. 8(6). 95–102. 2 indexed citations
14.
Na, Hyon Bin, Jung Hee Lee, Kwangjin An, et al.. (2007). Development of a T1 Contrast Agent for Magnetic Resonance Imaging Using MnO Nanoparticles. Angewandte Chemie International Edition. 46(28). 5397–5401. 518 indexed citations breakdown →
15.
Lee, Sa-Won, et al.. (2007). Ionically Fixed Polymeric Nanoparticles as a Novel Drug Carrier. Pharmaceutical Research. 24(8). 1508–1516. 35 indexed citations
16.
Choi, Young Hee, Soo Kyung Bae, Jung Mi Oh, Sun‐Ok Kim, & Myung G. Lee. (2007). Pharmacokinetics of intravenous methotrexate in mutant Nagase analbuminemic rats. Biopharmaceutics & Drug Disposition. 28(7). 385–392. 14 indexed citations
17.
Kim, Sun‐Ok, et al.. (2005). DEVELOPMENT OF ULTRA-LIGHT 2-AXES SUN SENSOR FOR SMALL SATELLITE. Journal of Astronomy and Space Sciences. 22(1). 47–58. 3 indexed citations
18.
Kim, Sun‐Ok, Shalom Avraham, Shuxian Jiang, et al.. (2004). Differential expression of Csk homologous kinase (CHK) in normal brain and brain tumors. Cancer. 101(5). 1018–1027. 20 indexed citations
19.
Ha, Hunjoo, et al.. (2000). KR 31372, a benzopyran derivative, inhibits oxidized LDL‐stimulated proliferation and migration of vascular smooth muscle cells. Fundamental and Clinical Pharmacology. 14(5). 469–476. 5 indexed citations
20.
Kim, Sun‐Ok, et al.. (1994). Production and Purification of Recombinant Human Insulin-like Growth Factor I from Escherichia coli. Molecules and Cells. 4(4). 467–472. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026